Preclinical activity, current status of potent P-glycoprotein inhibitor discussed at congress July 19, 1999 No Comments
New cytoprotective compound that acts by inhibiting PARP activity developed at N-Gene July 19, 1999 No Comments
First clinically evaluated ribozyme-based product proves safe in volunteers and patients July 16, 1999 No Comments
RSS